Furthermore, compared to other ABC transporters like ABCC1 and ABCC4, ABCC5 more directly reflects HCC progression and drug resistance, making it highly valuable for precision medicine and targeted therapies in liver cancer. This evidence concerns the gene ABCC1 and hepatocellular carcinoma.